- ByReuters-
(Reuters) - U.S. drugmaker Amgen (NASDAQ:AMGN)'s shares jumped 13% to $316.26 premarket on Friday as the company teased encouraging data for its experimental obesity drug,...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
178.85 | 178.90 | 172.25 | +7.39 | +4.31% | 10.19M | ||
160.73 | 161.77 | 159.89 | +1.10 | +0.69% | 8.57M | ||
335.44 | 336.16 | 329.25 | +4.37 | +1.32% | 2.39M | ||
30.51 | 30.67 | 30.19 | +0.14 | +0.46% | 47.87M | ||
397.84 | 399.93 | 394.65 | +2.90 | +0.73% | 17.21M | ||
112.62 | 112.87 | 110.56 | +2.14 | +1.94% | 6.77M | ||
56.83 | 57.76 | 56.39 | -0.40 | -0.70% | 4.43M | ||
46.79 | 47.12 | 46.60 | -0.05 | -0.11% | 14.87M | ||
432.57 | 433.65 | 428.17 | +5.62 | +1.32% | 2.08M | ||
191.66 | 193.50 | 189.52 | -0.20 | -0.10% | 6.49M | ||
61.99 | 62.40 | 61.72 | +0.06 | +0.10% | 10.97M | ||
273.28 | 276.31 | 272.71 | -1.15 | -0.42% | 3.08M | ||
128.26 | 129.69 | 127.99 | -0.54 | -0.42% | 7.42M | ||
96.81 | 98.40 | 96.65 | -1.63 | -1.66% | 6.26M | ||
173.18 | 173.41 | 170.89 | +3.88 | +2.29% | 70.88M | ||
184.72 | 185.10 | 179.91 | +5.72 | +3.20% | 53.09M | ||
278.39 | 278.63 | 274.90 | +1.02 | +0.37% | 2.63M | ||
59.71 | 59.88 | 58.58 | +0.86 | +1.46% | 15.74M | ||
335.53 | 336.00 | 330.98 | +3.56 | +1.07% | 3.13M | ||
164.69 | 164.88 | 162.62 | +0.26 | +0.16% | 3.82M | ||
38.93 | 39.48 | 38.75 | -0.27 | -0.69% | 17.22M | ||
214.37 | 215.07 | 212.42 | +1.22 | +0.57% | 975.01K | ||
149.92 | 152.33 | 149.14 | -1.26 | -0.83% | 8.33M | ||
232.50 | 233.95 | 230.91 | +1.04 | +0.45% | 2.7M | ||
193.64 | 196.48 | 192.68 | -1.66 | -0.85% | 3.1M | ||
272.13 | 273.08 | 267.94 | +3.44 | +1.28% | 3.65M | ||
267.61 | 269.47 | 266.65 | +0.29 | +0.11% | 5.04M | ||
492.97 | 493.69 | 483.94 | +8.86 | +1.83% | 3.2M | ||
92.41 | 92.45 | 90.91 | +2.07 | +2.29% | 7.26M | ||
163.84 | 164.49 | 162.64 | +0.44 | +0.27% | 5.59M |
(Reuters) - U.S. drugmaker Amgen (NASDAQ:AMGN)'s shares jumped 13% to $316.26 premarket on Friday as the company teased encouraging data for its experimental obesity drug,...
By Stephen Nellis (Reuters) - For most of the past year and a half, Apple (NASDAQ:AAPL) Chief Executive Tim Cook has fielded questions from Wall Street analysts about his plans...
Investing.com - April was a difficult month for European stock indices, but Barclays noted that overall earnings resilience has likely limited the downside for equities. European...
May is expected to be another volatile month on Wall Street amid a plethora of significant market-moving events. Identifying favorable opportunities becomes paramount in the...
How shall I put this? Let’s see: Apple (NASDAQ:AAPL) has delivered everything the bulls want on a silver platter. If the market doesn’t go raging to new highs today,...
Stocks rebounded yesterday, with the S&P 500 climbing by 90 bps, ahead of what will be another big data point and the last major data point until the CPI report. I am thankful....
Friday, May 3, 2024 | ||||||
Equinix(EQIX) | EPS / Forecast | Revenue / Forecast | 2.64 / 2.66 | 2.14B / 2.14B | ||
Hershey Co(HSY) | EPS / Forecast | Revenue / Forecast | -- / 2.76 | -- / 3.11B | ||
CBRE A(CBRE) | EPS / Forecast | Revenue / Forecast | -- / 0.6928 | -- / 7.94B | ||
Cboe Global(CBOE) | EPS / Forecast | Revenue / Forecast | -- / 2.04 | -- / 504.8M | ||
Trimble(TRMB) | EPS / Forecast | Revenue / Forecast | -- / 0.6191 | -- / 912.15M |